# ERA4Health IICS4all 2027

**Funder:** HRB
**Budget:** Up to €650,000 per grant (HRB contribution); up to €1,500,000 total HRB commitment to the call
**Deadline:** 14 January 2027 (11:00 GMT (12:00 CET); ECRIN engagement deadline 30 November 2026)
**Duration:** Up to 48 months
**Consortium:** Required — multi-national consortium of Partners across participating countries, with a single Host Institution/Lead Applicant contracted per country; additional associate partner clinical sites permitted
**Application:** 2-stage: joint pre-proposal → invited full proposal (budget/deliverables submitted by Irish partners)
**Frequency:** One-off
**Eligible countries:** IE
**Official call:** https://era4health.eu/calls/iics4all2027.php
**Last updated:** 8 Nov 2026

## Eligibility & scope

Supports multi-national investigator-initiated phase III randomised controlled clinical studies (comparative-effectiveness or drug repurposing) in cardiovascular, autoimmune, metabolic or non-communicable respiratory diseases, including underrepresented populations. Not open to Host Institutions in Northern Ireland; excludes cancer, basic/pre-clinical research, and commercial-purpose trials; joint proposal must be submitted in English.

## Summary

ERA4Health IICS4all 2027 funds multi-national, investigator-initiated phase III randomised controlled trials in cardiovascular, autoimmune, metabolic or non-communicable respiratory disease, including comparative-effectiveness and drug repurposing studies. HRB contributes up to €650,000 per grant to Irish partners within a multi-country consortium, as part of a wider €1.5 million commitment to this one-off call. Cancer, basic/pre-clinical research and commercial-purpose trials are excluded, and Host Institutions in Northern Ireland are not eligible.

## Who should apply

- Investigators leading multi-national phase III randomised controlled trials
- Irish-based Host Institutions/Lead Applicants partnering with teams across participating countries
- Researchers in cardiovascular, autoimmune, metabolic or non-communicable respiratory disease
- Comparative-effectiveness or drug repurposing trial designs, including underrepresented populations
- Not applicable to Host Institutions in Northern Ireland

## Key dates

- Pre-proposal deadline 14 January 2027, 11:00 GMT (12:00 CET)
- ECRIN engagement deadline 30 November 2026
- Two-stage process: joint pre-proposal then invited full proposal; up to 48-month project duration

## Tips for applicants

- Engage with ECRIN well before the 30 November 2026 deadline if clinical trial infrastructure support is needed for the consortium.
- Confirm each country's Host Institution/Lead Applicant arrangement early, since only one is contracted per country alongside associate clinical sites.
- The joint proposal must be submitted in English even though HRB funds only the Irish partner's budget and deliverables at full-proposal stage.

## Frequently asked questions

### How much funding does ERA4Health IICS4all 2027 provide?

HRB contributes up to €650,000 per grant to Irish partners, with up to €1.5 million total committed by HRB to this call.

### What diseases does this call fund research on?

It funds phase III randomised controlled trials in cardiovascular, autoimmune, metabolic or non-communicable respiratory disease; cancer and basic/pre-clinical research are excluded.

### Is a consortium required for this grant?

Yes, a multi-national consortium of partners across participating countries is required, with one Host Institution/Lead Applicant contracted per country.

### Can Northern Ireland institutions apply?

No, Host Institutions in Northern Ireland are not eligible for this call.

### How long can an ERA4Health IICS4all project run?

Projects can run for up to 48 months.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/hrb-era4health-iics4all-2027) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md&grant=hrb-era4health-iics4all-2027).